share_log

賽生藥業:根據《收購守則》規則22作出的交易披露

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Hong Kong Stock Exchange ·  Apr 17 05:27
Summary by Moomoo AI
赛生药业控股有限公司於2024年4月16日宣布,其全資子公司SciClone Option Management Limited通過協議安排進行了股份交易,涉及賣出254,000股股份。該交易是為了滿足根據公司購股權激勵計劃行使的購股權,每股交易價格為1.6562港元。此次股份賣出後,SciClone Option Management Limited持有的赛生药业股份比例為2.6023%。該交易由Maples Trustee Services (Cayman) Limited作為賽生信託的受託人全資擁有,並於2024年4月11日完成。
赛生药业控股有限公司於2024年4月16日宣布,其全資子公司SciClone Option Management Limited通過協議安排進行了股份交易,涉及賣出254,000股股份。該交易是為了滿足根據公司購股權激勵計劃行使的購股權,每股交易價格為1.6562港元。此次股份賣出後,SciClone Option Management Limited持有的赛生药业股份比例為2.6023%。該交易由Maples Trustee Services (Cayman) Limited作為賽生信託的受託人全資擁有,並於2024年4月11日完成。
Sai Sing Pharmaceutical Holdings Limited announced on 16 April 2024 that SciClone Option Management Limited, its wholly-owned subsidiary SciClone Option Management Limited, has entered into a share transaction involving the sale of 254,000 shares. The transaction was to satisfy the call options exercised under the Company's Share Option Incentive Scheme at a trading price of HK$1.6562 per share. Following the share sale, SciClone Option Management Limited's stake in Saigon Pharmaceuticals is 2.6023%. The transaction is wholly owned by Maples Trustee Services (Cayman) Limited as the trustee of the Caisson Trust and was completed on 11 April 2024.
Sai Sing Pharmaceutical Holdings Limited announced on 16 April 2024 that SciClone Option Management Limited, its wholly-owned subsidiary SciClone Option Management Limited, has entered into a share transaction involving the sale of 254,000 shares. The transaction was to satisfy the call options exercised under the Company's Share Option Incentive Scheme at a trading price of HK$1.6562 per share. Following the share sale, SciClone Option Management Limited's stake in Saigon Pharmaceuticals is 2.6023%. The transaction is wholly owned by Maples Trustee Services (Cayman) Limited as the trustee of the Caisson Trust and was completed on 11 April 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more